| Summary: | BackgroundMethod of levels (MOL) is an innovative transdiagnostic cognitive therapy with potential advantages over existing psychological treatments for psychosis.AimsThe Next Level study is a feasibility randomised controlled trial (RCT) of MOL for people experiencing first-episode psychosis. It aims to determine the suitability of MOL for further testing in a definitive trial (trial registration ISRCTN13359355).MethodThe study uses a parallel group non-masked feasibilityRCT design with two conditions: (a) treatment as usual (TAU) and (b) TAU plus MOL. Participants (n = 36) were recruited from early intervention in psychosis services. Outcome measures are completed at baseline, 10 and 14 months. The primary outcomes are recruitment and retention.ResultsParticipants’ demographic and clinical characteristics are presented along with baseline data.ConclusionsNext Level has recruited to target, providing evidence that it is feasible to recruit to a RCT of MOL for first-episode psychosis.Declaration of interestNone.
|
|---|